LifeMD (LFMD) Return on Equity (2013 - 2025)

LifeMD has reported Return on Equity for 13 years, with the latest figure at 0.01% in Q4 2025.

• For the quarter ending Q4 2025, Return on Equity fell 4.0% year-over-year to 0.01%; the trailing twelve-month figure through Dec 2025 stood at 0.01% (down 4.0% YoY), and the FY2025 full-year result was 0.04%, up 4.0% from the prior year.
• Return on Equity for Q4 2025 stood at 0.01%, down from 0.0% in the prior quarter.
• The five-year high for Return on Equity was 0.26% in Q1 2021, with the low at 0.93% in Q3 2022.
• Historically, Return on Equity has averaged 0.08% across 5 years, with a median of 0.02% in 2023.
• Annual changes were most pronounced in 2022 — Return on Equity plunged 99 bps — and 2023, when it jumped 95 bps.
• LifeMD's Return on Equity stood at 0.4% in 2021, then soared by 117 bps to 0.07% in 2022, then declined by 27 bps to 0.05% in 2023, then dropped by 28 bps to 0.04% in 2024, then tumbled by 117 bps to 0.01% in 2025.
• The last three Return on Equity figures came in at 0.01% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025), per Business Quant data.